Lopinavir and Ritonavir Tablets IP 200mg/50mg Manufacturer, Supplier, and PCD Pharma Franchise in India

Leading Lopinavir and Ritonavir Tablets Manufacturer from Vapi, Gujarat

At Taj Pharmaceuticals Ltd., we are proud to be a top manufacturer and exporter of Lopinavir and Ritonavir Tablets IP 200mg/50mg in India, with a robust presence across Mumbai, Maharashtra, and nationwide operations covering PAN India. Our manufacturing facility in Vapi, Gujarat, operates under WHO-GMP and ISO certifications, producing world-class antiretroviral medications trusted by healthcare providers across the globe.

Our Lopinavir and Ritonavir Tablets are formulated to combat HIV-1 infection by inhibiting protease enzymes responsible for viral replication. With proven clinical efficacy, our tablets help reduce the viral load and strengthen the immune response in affected individuals.

Pharmaceutical Excellence with Global Compliance

Taj Pharmaceuticals upholds international standards at every step of production. Our Lopinavir and Ritonavir 200mg/50mg tablets are manufactured in state-of-the-art plants, backed by cutting-edge technology and comprehensive quality assurance protocols. Each batch undergoes rigorous analytical testing to ensure purity, potency, and safety, complying with guidelines from WHO, DCGI, EU GMP, and other global authorities.

We are committed to maintaining consistency in formulation, packaging, and delivery, ensuring healthcare systems and patients receive high-quality antiretroviral solutions without delay.

Widest Distribution Network Across PAN India

We provide seamless supply to healthcare institutions, pharmaceutical distributors, and NGOs across:

  • Mumbai
  • Delhi
  • Bangalore
  • Hyderabad
  • Ahmedabad
  • Kolkata
  • Pune
  • Chennai
  • Lucknow
  • Pan India Tier-1 & Tier-2 cities

Our logistics team ensures on-time delivery, even in high-demand regions and remote healthcare zones, meeting urgent therapeutic needs with efficiency.

PCD Pharma Franchise for Lopinavir and Ritonavir Tablets

Taj Pharmaceuticals offers exclusive PCD Pharma Franchise opportunities for its high-demand antiretroviral range. With our franchise model, partners benefit from:

  • Monopoly rights in selected regions
  • Marketing support and promotional materials
  • Competitive pricing structure
  • Regulatory support and documentation
  • 24/7 customer service and logistics assistance

Join hands with a reputable manufacturer and scale your pharmaceutical business with a reliable supply of Lopinavir and Ritonavir Tablets IP 200mg/50mg.

Private Labeling and Third-Party Manufacturing Services

Taj Pharmaceuticals also specializes in private labeling and third-party contract manufacturing for pharmaceutical brands worldwide. Our services include:

  • Custom branding and packaging
  • Product registration assistance
  • Full regulatory compliance support
  • Affordable bulk pricing
  • Prompt production and dispatch timelines

Whether you’re expanding your existing brand or launching a new one, we deliver tailor-made solutions for Lopinavir and Ritonavir Tablets manufacturing.

Why Choose Taj Pharmaceuticals?

1. Proven Manufacturing Expertise
With decades of pharmaceutical innovation, Taj Pharmaceuticals remains one of the most trusted names in antiretroviral drug manufacturing in India.

2. International Reach
We export to over 40 countries, including Africa, Latin America, the Middle East, and Southeast Asia, meeting the needs of both public health organizations and private enterprises.

3. Cost-Effective Pricing
Our efficient manufacturing allows us to offer competitive rates without compromising on quality, helping healthcare providers deliver affordable HIV care.

4. Quality and Safety Compliance
Our products adhere to stringent pharmacovigilance, batch traceability, and validated stability data, ensuring absolute peace of mind.

5. Comprehensive Support
From dossier preparation to logistics management, we offer complete end-to-end support, making us your ideal pharmaceutical partner.

Dosage and Administration of Lopinavir and Ritonavir Tablets IP 200mg/50mg

  • Form: Film-coated tablets
  • Dosage Strength: Lopinavir 200mg + Ritonavir 50mg
  • Route: Oral
  • Recommended Use: Take with food for improved absorption
  • Administration: Usually 1–2 times daily, as prescribed by a healthcare professional
  • Indications: For the management of HIV-1 infection in combination with other antiretroviral agents

Possible Side Effects

While effective, Lopinavir and Ritonavir Tablets may cause side effects, which include:

  • Headache
  • Diarrhea
  • Nausea or vomiting
  • Elevated liver enzymes
  • Peripheral neuropathy
  • Increased lipid levels
  • Weight gain
  • Possible bone density reduction

Patients are advised to consult healthcare providers regularly, especially during long-term therapy, and supplement with calcium and vitamin D as needed.

Packaging and Storage

  • Blister and HDPE bottle packs available
  • Shelf life: 24 to 36 months
  • Storage: Store in a cool, dry place away from direct sunlight
  • Labeling: Available in English and multilingual packaging

Global Market Presence

Taj Pharmaceuticals proudly exports Lopinavir and Ritonavir Tablets IP 200mg/50mg to international buyers and NGOs such as:

  • UNICEF
  • WHO-affiliated healthcare agencies
  • MSF (Doctors Without Borders)
  • Government procurement bodies

We ensure fast-track documentation, COAs, COPPs, and support for product registration in multiple regulatory jurisdictions.

Certifications and Accreditations

  • WHO-GMP Certified
  • ISO 9001:2015
  • FDA (India) Approved
  • EU GMP-compliant infrastructure
  • D&B Verified Manufacturer
  • Certified by Indian Pharmaceutical Export Promotion Council (Pharmexcil)

Contact Taj Pharmaceuticals for Lopinavir and Ritonavir Tablets

Corporate Office – Mumbai, Maharashtra, India
Manufacturing Site – Vapi, Gujarat, India

Email: info@tajpharma.com
Phone: +91-22-2637 3050
Website: www.tajpharma.com

Partner with Taj Pharmaceuticals—India’s leading manufacturer and exporter of Lopinavir and Ritonavir Tablets IP 200mg/50mg—and ensure access to reliable, quality-driven HIV treatment solutions at scale.